KORRO BIO
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,
KORRO BIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.korrobio.com
Total Employee:
51+
Status:
Active
Total Funding:
207.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sixty Degree Capital
Sixty Degree Capital investment in Series B - Korro Bio
Point72
Point72 investment in Series B - Korro Bio
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series B - Korro Bio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Korro Bio
Surveyor Capital
Surveyor Capital investment in Series B - Korro Bio
Invus
Invus investment in Series B - Korro Bio
New Enterprise Associates
New Enterprise Associates investment in Series B - Korro Bio
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Korro Bio
Verition Fund Management
Verition Fund Management investment in Series B - Korro Bio
Monashee Investment Management
Monashee Investment Management investment in Series B - Korro Bio
Official Site Inspections
http://www.korrobio.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.49 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Korro Bio"
Home - Korro Bio
Nov 14, 2024 Our science. Our approach to edit RNA involves redirecting a naturally occurring editing process that’s inside every cell in the human body. This is accomplished by delivering a chemically modified RNA that helps to target …See details»
About Us - Korro Bio
Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.See details»
Korro Bio - Crunchbase Company Profile & Funding
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing.See details»
Korro Bio, Inc. | LinkedIn
Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base ...See details»
Korro Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Dec 3, 2023 www.korrobio.com. Public Company | 2018 | Massachusetts, United States | 100-250 | NASDAQ: KRRO | www.korrobio.com. Last update 01 Nov 2024. Overview. Pipeline. …See details»
Korro Bio Company Profile | Management and Employees List
SQL International Organization for Standardization . Java Oracle . Frameworks and Libraries (4 Technologies) PyTorch PyTorch . Django Django Software Foundation . jQuery . ...See details»
Korro Bio, Inc. Company Overview, Contact Details & Competitors …
Frequently Asked Questions Where is Korro Bio, Inc. 's headquarters located? Korro Bio, Inc. 's main headquarters is located at One Kendall Square, Building 600-700 Suite 6-401 …See details»
Korro Bio Company Profile 2024: Stock Performance
Korro Bio General Information Description. Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare …See details»
Contact - Korro Bio
60 First Street. You are leaving the Korro Bio website. You may return to the Korro Bio website by closing the window to the third-party website you have opened.See details»
Korro Bio, Inc. Information - RocketReach
Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base …See details»
Working At Korro Bio: Company Overview and Culture - Zippia
Www.korrobio.com. Organization Type. Private. Social Media. Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular …See details»
Korro Bio - Overview, News & Similar companies | ZoomInfo.com
May 30, 2024 Korro Bio contact info: Phone number: (617) 468-1999 Website: www.korrobio.com What does Korro Bio do? Korro Bio is a biopharmaceutical company with a …See details»
Release Details - Korro Bio, Inc.
CAMBRIDGE, Mass., May 10, 2023 — Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced the …See details»
Korro Bio - Craft
Korro Bio has 5 employees at their 1 location and $91.5 m in total funding,. See insights on Korro Bio including office locations, competitors, revenue, financials, executives, subsidiaries and …See details»
SEC Filing – Korro Bio, Inc.
Nov 12, 2024 Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, …See details»
SEC Filing – Korro Bio, Inc.
Incorporation or organization) (I.R.S. Employer. Identification Number) 60 First Street, 2 nd floor, Suite 250 . Cambridge, Massachusetts 02141 (617) 468-1999 ... Our website address is …See details»
Our Science - Korro Bio
Our approach. Mammals and other lower species like cephalopods have an endogenous process of modifying single bases on RNA, referred to as RNA editing.See details»
Press Releases – Korro Bio, Inc.
Nov 12, 2024 CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a …See details»
Careers - Korro Bio
At Korro Bio, our passion for scientific innovation drives us to advance medicine. Join us in developing RNA editing technologies and groundbreaking treatmen...See details»
Pipeline - Korro Bio
We are developing KRRO-110 as a potential differentiated and disease-modifying treatment for alpha-1 antitrypsin deficiency (AATD). AATD is caused by mutations in the SERPINA1 gene, …See details»